Vertex Pharmaceuticals
VRTX
VRTX
501 hedge funds and large institutions have $18.7B invested in Vertex Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 58 funds opening new positions, 198 increasing their positions, 180 reducing their positions, and 70 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
17% less first-time investments, than exits
New positions opened: 58 | Existing positions closed: 70
37% less capital invested
Capital invested by funds: $29.5B → $18.7B (-$10.8B)
Holders
501
Holding in Top 10
5
Calls
$61.1M
Puts
$72.7M
Top Buyers
| 1 | +$559M | |
| 2 | +$418M | |
| 3 | +$139M | |
| 4 |
O
OrbiMed
New York
|
+$108M |
| 5 |
GE
General Electric
Evendale,
Ohio
|
+$100M |
Top Sellers
| 1 | -$315M | |
| 2 | -$179M | |
| 3 | -$121M | |
| 4 |
Jennison Associates
New York
|
-$93.1M |
| 5 |
JP Morgan Chase
New York
|
-$84.1M |